clinical trial · NCT05455749
Effect of holoBLG on Cat Allergic Patients
Allergy to CatsAllergic RhinoconjunctivitisholoBLG
brief summary
The aim of the study is to investigate the antigen-unspecific effect of a 3 months supplementation with a food for special medical purposes (FSMP) in form of a lozenge containing beta-lactoglobulin (BLG), iron, retinoic acid, zinc and polyphenols (holo-BLG) in patients with allergic rhinoconjunctivitis caused by cat (hair/dander) and the associated symptoms (symptom type and severity) during exposure to cat allergen in an Allergen Exposure Chamber (AEC).
started
Oct 4, 2021
primary completion
Mar 15, 2022
completion
Mar 16, 2022
last updated
Dec 18, 2023
official title
A Prospective Pilot Study to Observe the Effects of Cat Exposure in an Allergen Exposure Chamber (AEC) in Cat Allergic Patients Taking a Food for Special Medical Purposes (holoBLG) for 3 Months
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol